March 31 (Reuters) - Fusen Pharmaceutical Co Ltd 1652.HK:
FY GROSS MARGIN 49.9%
FY GROSS PROFIT RMB 162.6 MILLION
FY REVENUE RMB 326 MILLION
FY LOSS ATTRIBUTABLE RMB188.8 MILLION
Further company coverage: 1652.HK
((Reuters.Briefs@thomsonreuters.com;))